Studies have demonstrated that the phosphatase PP2A and the transcription factor p53 can promote cancer cell adaptation to glutamine deprivation in colon cancer line (Reid et al., 2013; Tajan et al., 2018) as well as other mechanisms (Pan et al., 2016; Takeuchi et al., 2018). Here, TP53 is linked to malignant colon neoplasm.